Pfizer Starts mRNA Flu Vaccine Trial, Designed Like Its Covid Jab

US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 shot.